Sweilem B Al Rihani

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Cognitive Impairment

Subarachnoid Hemorrhage

Community Dwelling

Top Venues

International journal of molecular sciences

Journal of clinical medicine

Journal of the American Geriatrics Society

This page only lists publications with an associated author ORCID identifier.

Publications

Sweilem B Al Rihani, Yazan S Batarseh, Amal Kaddoumi
The Blood-Brain Barrier in Health and Disease. International journal of molecular sciences 24 (11) (2023)
Meghan Ha, Anna Furman, Sweilem B Al Rihani, Veronique Michaud, Jacques Turgeon, David L Bankes
Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly. Journal of the American Geriatrics Society 70 (11) (2022)
Malavika Deodhar, Sweilem B Al Rihani, Lucy Darakjian, Jacques Turgeon, Veronique Michaud
Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition. Pharmaceutics 13 (2) (2021)
Sweilem B Al Rihani, Lucy I Darakjian, Malavika Deodhar, Pamela Dow, Jacques Turgeon, Veronique Michaud
Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level. International journal of molecular sciences 22 (7) (2021)
Abubakar Wani, Sweilem B Al Rihani, Ankita Sharma, Brenna Weadick, Rajgopal Govindarajan, Sameer U Khan, Parduman R Sharma, Ashish Dogra, Utpal Nandi, Chilakala N Reddy, Sonali S Bharate, Gurdarshan Singh, Sandip B Bharate, Ram A Vishwakarma, Amal Kaddoumi, Ajay Kumar
Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway. Autophagy 17 (11) (2021)
Malavika Deodhar, Sweilem B Al Rihani, Meghan J Arwood, Lucy Darakjian, Pamela Dow, Jacques Turgeon, Veronique Michaud
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice. Pharmaceutics 12 (9) (2020)
Sweilem B Al Rihani, Matt K Smith, Ravil Bikmetov, Malavika Deodhar, Pamela Dow, Jacques Turgeon, Veronique Michaud
Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy. Journal of clinical medicine 9 (8) (2020)